期刊文献+

非小细胞肺癌中ASPP1、ASPP2的表达及与p53的相关性 被引量:1

Expression of ASPP1,ASPP2 and their correlation with p53 in non-small cell lung cancers
下载PDF
导出
摘要 目的:检测非小细胞肺癌(NSCLC)中抑癌基因ASPP1、ASPP2的表达,研究其与肺癌临床特征的关系,并探讨其与p53的相关性。方法:利用组织芯片技术结合免疫组织化学Envision法检测ASPP1、ASPP2和p53蛋白在90例NSCLC和25例相应癌旁正常组织中的表达。结果:NSCLC组织中ASPP1的表达显著低于癌旁正常组织(P<0.05),ASPP1的表达与NSCLC的分化程度、临床分期及淋巴结转移相关(P<0.05);ASPP2在NSCLC及癌旁正常组织中的表达差异无显著性(P>0.05),ASPP2蛋白的表达与NSCLC的临床病理特征无关(P>0.05);ASPP1和p53表达呈负相关(r=-0.259,P=0.014),ASPP2和p53的表达状态无关(r=-0.119,P=0.264)。结论:ASPP1蛋白的低表达与NSCLC的恶性进展有关,ASPP1可能在诱导野生型p53细胞凋亡通路中起重要作用,ASPP2蛋白在NSCLC中与p53的表达无关,且可能不具有肿瘤特异性。 Objective To investigate the expression and clinical significance of ASPP1, ASPP2 and p53 and to explore their significance in non-small-cell lung cancer (NSCLC). Methods The expression levels of ASPPl, ASPP2 and p53 protein were examined in lung carcinoma tissue (n = 90), and pericancerous tissues (n = 25)by tissue microarray technique and immunohistochemistry staining. Results The positive rate of ASPP1 was significantly lower in cancer tissues than in their normal adjacent tissues (P 〈 0.05). The expression of ASPP1 had close relation with the differentiation, TNM stage and lymph node metastasis in NSCLC (P 〈 0.05). There was no significant difference between lung cancer tissue and the side-carcinoma tissues in expression of ASPP2 (P 〉 0.05 ). There was a negative correlation between the expressions of ASPP1 and p53 (r = -0.259,P = 0.014), but the expression of ASPP2 was not associated with p53 state (r = -0.119, P = 0.264). Conclusion The decrease of ASPP1 expression may contribute to invasion and metastasis in NSCLC, and ASPP1 may regulate the tumor apoptosis by inducing wide type p53 ; the expression of ASPP2 protein was not associated with the expression of p53 and the tumor specific in NSCLC.
出处 《实用医学杂志》 CAS 北大核心 2012年第1期64-67,共4页 The Journal of Practical Medicine
基金 云南省科技计划项目(编号:2008ZC140M)
关键词 非小细胞肺 ASPP P53 组织芯片 免疫组织化学 Carcinoma, non-small-cell lung ASPP p53 Tissue microarray Immunohistochemitry
  • 相关文献

参考文献10

  • 1Mitsudomi T, Hamajima N, Ogawa M, et al. Prognostic significance of p53 alterations in patients with non-small celllung cancer: a meta-analysis [J]. Clin Cancer Res,2000,6 (10) :4055-4063.
  • 2Samuels-Lev Y, O'Connor D J, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53 [J]. Mol Cell, 2001, 8(4) :781-794.
  • 3苏胜发,卢冰,苏敏,李大中,何常,钟愉.非小细胞肺癌中ASPP1、ASPP2蛋白的不同表达状态及其意义[J].肿瘤预防与治疗,2008,21(2):123-126. 被引量:6
  • 4Sullivan A, Lu X. ASPP: a new family of oncogenes and tumour suppressor genes [ J]. Br J Cancer, 2007,96 (2) : 196- 200.
  • 5Mori S, ho G, Usanmi N, et al. p53 apoptotic pathway molecules are frequently and simultaneously altered in non- small cell lung carcinoma [J]. Cancer, 2004,100(8) : 1673-1682. Mo.
  • 6ri T, Okamoto H, Takahashi N, et al. Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines [J]. FEBS Lett, 2000, 465(2-3) : 124-128.
  • 7Robinson R A, Lu X, Jones E Y, et al. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, p73 [J]. Structure, 2008, 16 (2):259-268.
  • 8胡红艳,魏万里.ASPP基因家族与肿瘤的研究进展[J].实用医学杂志,2009,25(15):2593-2595. 被引量:4
  • 9Lopez C D, Ao Y, Rohde L H, et al. Proapoptotic p53 interacting protein 53BP2 is induced by UV irradiation but suppressed by p53 [J]. Mol Cell Biol,2000,20 (21):8018- 8025.
  • 10李士军,张明霞,张明芳,肖晓光,施广霞.非小细胞肺癌细胞p53凋亡刺激蛋白家族的表达及调节[J].实用医学杂志,2009,25(4):521-523. 被引量:4

二级参考文献15

  • 1Samuels-Lev Y, O'Connor D J, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53 [J ]. Mol Cell, 2001,8(4) :781-794.
  • 2Mori T, Okamoto H, Takahashi N, et al. Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines [J]. FEBS Lett, 2000,465 (2-3) : 124-128.
  • 3Wong M L, Mcdrano J F. Real-time PCR for mRNA quantitation [ J ]. Biotechniques, 2005,39 ( 1 ) : 1-11.
  • 4Trigiante G, Lu X. ASPPs and cancer [J]. Nat Rev Cancer, 2006, 6(3) :217-226.
  • 5Iwabuchi K, Li B, Massa H F, et al. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2 [J]. J Biol Chem, 1998,273(40):26061-26068.
  • 6Bergamaschi D, Samuels Y, Jin B, et al. ASPP1 and ASPP2: common activators of p53 family members [ J ]. Mol Cell Biol, 2004, 24(3 ) : 1341-1350.
  • 7Agirre X, Roman-Gomez J, Jimenez-Velasco A, et al. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia [J]. Oncogene, 2006, 25(13) : 1862-1870.
  • 8Slee E A, Lu X. The ASPP family: deciding between life and death after DNA damage [J]. Toxicol Lett, 2003,139(2-3) : 81-87.
  • 9[2]Susan Haupt1.Apoptosis -the p53 network[J].Journal of Cell Science,2003,116:4077-4085.
  • 10[3]David Lane.How cells choose to die[J].Nature,2001,414:25-26.

共引文献11

同被引文献19

  • 1Moore BW, Perez VJ, Gehring M. Assay and regional distribution of a soluble protein characteristic of the nervous system [J]. J Neurochem, 1968,15 (4):265-272.
  • 2Kasahara K, Goto H, Enomoto M, et al. 14-3-3 gamma mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage [J]. EMBO J, 2010,29(16):2802-2812.
  • 3Goto H, Izawa I, Li P, et al. Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti-cancer therapy [J]. Cancer Sci, 2012,103(7): 1195-1200.
  • 4Kasahara K, Goto H, Izawa I, et al. PI 3-kinase-dependent phosphorylation of Plk I-Ser99 promotes association with 14-3-3gamma and is required for metaphase-anaphase transition [J]. Nat Commun,2013,4:1882-19oo.
  • 5Miyamoto T, Kitamura N, Ono M, et al. Identification of 14-3-3 gamma as a Mieap-interacting protein and its role in mitochondrial quality control [J]. Sci Rep, 2012,2:379-390.
  • 6Radbakrishnan VM, Putnam CW, Qi W, et al. PS3 suppresses expression of the 14-3-3 gamma oncogene [J]. BMC Cancer, 2011,11: 378-389.
  • 7Radhakrishnan VM, Martinez JD. 14-3- 3 gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling [J]. PLoS One, 2010,5(7) :e11433.
  • 8Lee JH, Lu H. 14-3-3 Gamma inhibition of MDMX-mediated p21 turnover independent of p53 [J]. J Bioi Chern, 2011,286(7): 5136-5142.
  • 9Hsiao BY, Chang TK, Wu IT, et al. Rad GTPase inhibits the NFkappaB pathway through interacting with RelAI p6S to impede its DNA binding and target gene transactivation [J]. Cell Signal, 2014,26(7): 1437-1444.
  • 10Sehgal L, Mukhopadhyay A, Rajan A, et al. 14-3-3 gamma-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo [J]. J Cell Sci, 2014, 127(Pt 10) :2174-2188.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部